CHICAGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its ...
LAGUNA HILLS, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced that it has acquired an additional 176,422 HYPE tokens, ...
Tilray Brands stockholders can submit and upvote questions on Robinhood and Say Technologies, beginning today and until October 8, 2025. To submit questions ahead of the webcast visit the Tilray stock ...
RetinalGenix patents are among the industry’s broadest, providing strong protection for device, system, and digital workflow innovations. This intellectual property portfolio sets the Company apart ...
LEVI-04, a Novel Neurotrophin-3 Inhibitor, Demonstrates Clinically Meaningful Improvements in Pain and Physical Function across a Range of OA Outcomes, Including the Staircase-Evoked Pain Procedure ...
Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has signed a definitive equipment order and ...
Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) ...
Evaxion and MSD have agreed to extend the evaluation period for EVX-B2 as an amendment to the option and license agreement. The extension follows an expansion of the initial evaluation plan ...
The presentation slides to which they will be speaking will be posted to the Microbix website at along with other business information and its financial disclosures. About Microbix Biosystems Inc.
Helius Medical Technologies, Inc. (NASDAQ: HSDT), today announced the filing of its U.S. Food and Drug Administration (FDA) 510 (k) submission for the PoNS (Portable Neuromodulation Stimulator) device ...
Every autumn, emergency rooms see a dramatic spike in childhood asthma attacks. The perfect storm of ragweed pollen, temperature changes, back-to-school germs, and academic stress creates a dangerous ...
Rare waiver recognizes the global dataset already generated for VMX-C001 and streamlines the path to the important Japanese market Japan to be included in global EquilibriX-S Phase 3 trial of VMX-C001 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback